Please assess the completion status of the following clinical trial:

Trial Title: Lumbar Transforaminal Epidural Corticosteroid Injection(s) Versus Defined Physical Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Patient inclusion highlights: L4-5 or L5-S1 HNP with leg\>back pain; duration \< 12 weeks.~1. Low back pain episode less than or equal to 12 weeks in duration, within the current pain episode. This may be the initial pain episode or the onset of a most recent episode of pain, preceded by at least a six month pain free interval.~2. Visual analog score (VAS) or screening Likert pain scale score three day average and present pain of at least four/ten at baseline.~3. Age 18 to 64.~4. Subjects will have focal disc herniation with unilateral radicular/neurological deficits or correlating radicular symptoms. These radicular symptoms/signs are defined as pain or paresthesias below the knee, pain reproduction with straight-leg-raising and/or extension or quadrant maneuvers, and radicular pattern sensory, reflex or strength changes. These symptoms will be consistent with their level of nerve root impingement and will primarily involve the L5 and/or S1 roots.~5. Those with canal and foraminal compromise due to disc herniation at L4-5 with L5 \> L4 signs and symptoms WILL be included.~Exclusion Criteria:~1. Litigation.~2. Workers compensation.~3. Those receiving remuneration for their pain, e.g. disability.~4. Back pain greater than leg pain.~5. Scoliosis of \> 15 degrees~6. Those unable to read English and complete the assessment instruments.~7. Spondylolysis, with or without spondylolithesis, degenerative spondylolithesis, or stenosis due primarily to degenerative bony or soft tissue changes.~8. Systemic inflammatory arthritis (e.g. rheumatoid, lupus).~9. Addictive behaviour, severe clinical depression, or psychotic features.~10. Significant lower extremity pathology that effects gait.~11. Sustained cervical or thoracic pain that is present at a level \>4/10 on VAS.~12. Possible pregnancy or other reason that precludes the use of fluoroscopy.~13. Prior lumbar surgery~14. Prior epidural steroid injections for treatment of current episode or within the prior year~15. Bilateral radicular signs/symptoms (\< 90% laterality of pain intensity or bilateral neurological signs)~16. No more than 4 PT sessions for current episode

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Lumbar Transforaminal Epidural Corticosteroid Injection (Type: OTHER): None
- Physical Therapy (Type: OTHER): None
- Cohort observational (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).